# Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer

> **NCT03359980** · PHASE2 · COMPLETED · sponsor: **MaaT Pharma** · enrollment: 24 (actual)

## Conditions studied

- Fecal Microbiota Transplantation

## Interventions

- **DRUG:** fecal microbiota transfer

## Key facts

- **NCT ID:** NCT03359980
- **Lead sponsor:** MaaT Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-13
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-11-26
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359980, "Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03359980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*